期刊文献+

未成熟血小板分数对化疗患者输注血小板的预测作用 被引量:1

The role of immature platelet fraction in the prediction of platelet transfusion in cancer patients after chemotherapy
下载PDF
导出
摘要 目的:通过检测外周血的未成熟血小板分数(IPF%)了解骨髓生成释放血小板(PLT)的能力,以期预测化疗患者是否需要输注PLT,避免不必要的PLT输注。方法:收集温州医科大学附属第二医院化疗住院患者186例,其中输血组74例、未输血组112例,利用SYSMEX XE-5000全自动血液分析仪的网织红细胞通道检测患者血常规标本的IPF%、IPF及PLT等指标,比较输血组和未输血组各检测指标的差异。接着对输血组患者的血小板和IPF%进行动态观察,并利用ROC曲线评价各项指标预测是否需输注PLT的效果。结果:输血组的,10.68%)]高于未输血组的,3.50%)],差异有统计学意义(P<0.05)。而输血组的,123.75×109/L)]低于未输血组[150.50×109/L(94.75×109/L,209.00×109/L)],差异有统计学意义(P<0.05)。动态结果分析发现IPF%随着PLT的下降而升高。通过ROC曲线分析发现IPF%的AUC和PLT的AUC没有差异。结论:IPF%升高提示外周血中PLT破坏增加,但尚无法作为化疗患者是否需输注PLT的预测指标。 Objective:To investigate whether immature platelet fraction(IPF%)predicate imminent platelet recovery after chemotherapy for the cancer patients,so that unnecessary platelet transfusion can be avoided.Methods:A total of 186 patients were enrolled and divided into blood transfusion group and non-transfusion group.IPF%of anticoagulated blood with EDTA-K2 was evaluated by means of the IPF master program equipped with SYSMEX XE-5000.The differences between IPF%and PLT of blood transfusion group were analyzed dynamically.The ROC curve was performed to evaluate the effect of those indictors in predicting whether PLT transfusion was needed.Results:The IPF%in the blood transfusion group[5.10%(2.48%,10.68%)]was higher than that in the non-transfusion group[1.85%(1.20%,3.50%)],and the blood platelet count in the blood transfusion group[35.00×109/L(12.75×109/L,123.75×109/L)]was lower than in the non-transfusion group[150.50×109/L(94.75×109/L,209.00×109/L)](P<0.05).There was an increase of IPF%during PLT nadir.The results of ROC analysis demonstrated that there was no statistical difference between the AUC of PLT and IPF%.Conclusion:Increased IPF%indicates PLT destruction in peripheral blood,but IPF%measurement lacks the predictive power regarding imminent PLT recovery in cancer patients.Therefore decisions regarding prophylactic PC transfusions should not be based on this parameter.
作者 郭晶晶 沈文彩 叶宣梅 潘素贞 周莲莲 江明华 GUO Jingjing;SHEN Wencai;YE Xuanmei;PAN Suzhen;ZHOU Lianlian;JIANG Minghua(Department of Laboratory Medicine,the Second Affiliated Hospital of Wenzhou Medical University,Wenzhou,325027)
出处 《温州医科大学学报》 CAS 2018年第12期925-928,共4页 Journal of Wenzhou Medical University
基金 温州医科大学附属第二医院2018年度"育苗计划"(911396)
关键词 未成熟血小板分数 输注血小板 化学治疗 immature platelet fraction platelet transfusion chemotherapy
  • 相关文献

参考文献2

二级参考文献23

  • 1张之南;沈悌.血液病诊疗及疗效标准[M]北京:科学出版社,2007172.
  • 2Jung H,Jeon HK,Kim HJ. Immature platelet fraction:establishment of a reference interval and diagnostic measure for thrombocytopenia[J].Korean J Lab Med,2010,(05):451-459.
  • 3Albanyan A,Murphy MF,Wilcock M. Changes in the immature platelet fraction within ageing platelet concentrates[J].Journal of Thrombosis and Haemostasis,2008,(12):2213-2215.
  • 4Pons I,Monteagudo M,Lucchetti G. Correlation between immature platelet fraction and reticulated platelets.Usefulness in the etiology diagnosis of thrombocytopenia[J].European Journal of Haematology,2010,(02):158-163.
  • 5Briggs C,Kunka S,Hart D. Assessment of an immature platelet fraction(IPF)in peripheral thrombocytopenia[J].British Journal of Haematology,2004,(01):93-99.
  • 6Abe Y,Wada H,Tomatsu H. A simple technique to determine thrombopoiesis level using immature platelet fraction(IPF)[J].Thrombosis Research,2006,(04):463-469.
  • 7Yamaoka G,Kubota Y,Nomura T. The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell transplantation[J].Int J Lab Hematol,2010,(6 Pt 1):e208-e216.
  • 8Abe Y,Wada H,Sakakura M. Usefulness of fully automated measurement of reticulated platelets using whole blood[J].Clinical and Applied Thrombosis/Hemostasis,2005,(03):263-270.
  • 9Estcourt L J, Stanworth S J, Harrison P, et al. Prospective observa- tional cohort study of the association between thromboelastome- try, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study [J]. Br J Haematol, 2014,166(4):581-591.
  • 10Rodeghiero F, Michel M, Gernsheimer T, et al. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group [J].Blood, 2013,121 ( 14 ) : 2596-2606.

共引文献27

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部